MNOV
MEDICINOVA INC
NASDAQ · Healthcare · Biotechnology · US
$3.32
−3.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 45.00x
- P/S forward
- 260.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.38x
- Price / sales
- 177.53x
- Price / cash flow
- -0.08x
Enterprise value
- Enterprise value
- $138.1M
- EV / sales
- 150.05x
- EV / EBITDA
- -12.58x
- EV / EBIT
- -11.65x
- Market cap
- $163.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026